Daniel K. Langlois

636 total citations
43 papers, 424 citations indexed

About

Daniel K. Langlois is a scholar working on Small Animals, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Daniel K. Langlois has authored 43 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Small Animals, 11 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Nutrition and Dietetics. Recurrent topics in Daniel K. Langlois's work include Veterinary Medicine and Surgery (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Trace Elements in Health (9 papers). Daniel K. Langlois is often cited by papers focused on Veterinary Medicine and Surgery (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Trace Elements in Health (9 papers). Daniel K. Langlois collaborates with scholars based in United States, Canada and Israel. Daniel K. Langlois's co-authors include Kent R. Refsal, Rebecca C. Smedley, Amy M. Koenigshof, Rinosh Mani, John P. Buchweitz, William D. Schall, Pierrette Gaudreau, J.M. Kruger, Christelle Veyrat‐Durebex and Edmund J. Rosser and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Daniel K. Langlois

40 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel K. Langlois United States 12 108 90 90 84 64 43 424
Safrun Mahmood India 13 14 0.1× 99 1.1× 25 0.3× 50 0.6× 44 0.7× 41 354
Lambro A. Johnson Australia 15 44 0.4× 257 2.9× 98 1.1× 43 0.5× 25 0.4× 42 605
J Collins United Kingdom 13 41 0.4× 92 1.0× 220 2.4× 44 0.5× 8 0.1× 18 561
Shuang Shen China 13 19 0.2× 178 2.0× 36 0.4× 24 0.3× 73 1.1× 42 492
György Miklós Buzás Hungary 12 87 0.8× 145 1.6× 29 0.3× 39 0.5× 110 1.7× 58 542
David J. Honor Canada 9 94 0.9× 59 0.7× 31 0.3× 10 0.1× 45 0.7× 14 352
K Thamprasert Thailand 11 50 0.5× 52 0.6× 24 0.3× 11 0.1× 28 0.4× 25 314
Yurong Lu China 12 12 0.1× 180 2.0× 27 0.3× 32 0.4× 65 1.0× 19 557
James Owens United States 10 45 0.4× 79 0.9× 82 0.9× 11 0.1× 25 0.4× 15 403
Takuji Fujisawa Japan 13 38 0.4× 43 0.5× 69 0.8× 37 0.4× 56 0.9× 23 559

Countries citing papers authored by Daniel K. Langlois

Since Specialization
Citations

This map shows the geographic impact of Daniel K. Langlois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Langlois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Langlois more than expected).

Fields of papers citing papers by Daniel K. Langlois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K. Langlois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Langlois. The network helps show where Daniel K. Langlois may publish in the future.

Co-authorship network of co-authors of Daniel K. Langlois

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K. Langlois. A scholar is included among the top collaborators of Daniel K. Langlois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K. Langlois. Daniel K. Langlois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wennogle, Sara A. Jablonski, et al.. (2024). Association of time to start of enteral nutrition and outcome in cats with hepatic lipidosis. Journal of Veterinary Internal Medicine. 38(6). 3144–3152. 2 indexed citations
2.
Conley, Alan J., et al.. (2023). Case report: Androgen-secreting adrenocortical tumors in eight cats. Frontiers in Veterinary Science. 10. 1158142–1158142. 3 indexed citations
3.
Wennogle, Sara A. Jablonski, et al.. (2022). Relationship between serum magnesium, calcium, and parathyroid concentrations in dogs with abnormally low serum 25-hydroxyvitamin D concentration and chronic or protein-losing enteropathy. Journal of Veterinary Internal Medicine. 37(1). 101–109. 8 indexed citations
4.
Abuelo, Ángel, et al.. (2022). Peripheral biomarkers of oxidative stress in dogs with acute pancreatitis. Journal of Veterinary Internal Medicine. 36(6). 1958–1965. 5 indexed citations
5.
Cridge, Harry, Daniel K. Langlois, Jörg M. Steiner, & Robert A. Sanders. (2022). Cardiovascular abnormalities in dogs with acute pancreatitis. Journal of Veterinary Internal Medicine. 37(1). 28–36. 5 indexed citations
6.
Langlois, Daniel K., et al.. (2021). Multiple corticosteroid abnormalities in cats with hyperaldosteronism. Journal of Veterinary Internal Medicine. 35(5). 2152–2158. 8 indexed citations
7.
Anderson, Amanda L., Christine D. Harman, Laurence M. Occelli, et al.. (2021). Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®). BMC Veterinary Research. 17(1). 366–366. 3 indexed citations
8.
Refsal, Kent R., et al.. (2021). Retrospective study of aldosterone and progesterone secreting adrenal tumors in 10 cats. Journal of Veterinary Internal Medicine. 35(5). 2159–2166. 8 indexed citations
9.
Refsal, Kent R., et al.. (2021). Low-dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial. Journal of Veterinary Internal Medicine. 35(4). 1720–1728. 11 indexed citations
10.
Langlois, Daniel K., Amy M. Koenigshof, & Rinosh Mani. (2019). Metronidazole treatment of acute diarrhea in dogs: A randomized double blinded placebo-controlled clinical trial. Journal of Veterinary Internal Medicine. 34(1). 98–104. 42 indexed citations
11.
Langlois, Daniel K., et al.. (2019). Ammonium tetrathiomolybdate treatment of copper-associated hepatopathy in dogs. Journal of Veterinary Internal Medicine. 33(3). 1336–1343. 5 indexed citations
12.
Langlois, Daniel K., et al.. (2019). Constrictive Bronchiolitis Obliterans in a Dog. Journal of the American Animal Hospital Association. 55(2). e552–1. 2 indexed citations
13.
Langlois, Daniel K., Michele C. Fritz, William D. Schall, et al.. (2018). ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing’s syndrome. BMC Endocrine Disorders. 18(1). 24–24. 19 indexed citations
14.
Langlois, Daniel K., et al.. (2017). Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs. Journal of Veterinary Internal Medicine. 31(4). 1163–1169. 19 indexed citations
15.
Langlois, Daniel K., et al.. (2016). Evaluation of Basal Serum or Plasma Cortisol Concentrations for the Diagnosis of Hypoadrenocorticism in Dogs. Journal of Veterinary Internal Medicine. 30(6). 1798–1805. 49 indexed citations
16.
Langlois, Daniel K., John P. Buchweitz, Andreas F. Lehner, et al.. (2015). Pharmacologic evaluation of ammonium tetrathiomolybdate after intravenous and oral administration to healthy dogs. American Journal of Veterinary Research. 76(5). 445–453. 8 indexed citations
17.
Langlois, Daniel K., Andreas F. Lehner, John P. Buchweitz, et al.. (2013). Pharmacokinetics and Relative Bioavailability of d -Penicillamine in Fasted and Nonfasted Dogs. Journal of Veterinary Internal Medicine. 27(5). 1071–1076. 9 indexed citations
18.
Langlois, Daniel K., et al.. (2013). Successful Treatment of Intracardiac and Intraocular Blastomycosis in a Dog with Combination Azole Therapy. Journal of the American Animal Hospital Association. 49(4). 273–280. 2 indexed citations
19.
Dumont, Yvan, Pierrette Gaudreau, Manuela Mazzuferi, et al.. (2005). BODIPY®‐conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. British Journal of Pharmacology. 146(8). 1069–1081. 19 indexed citations
20.
Gaudreau, Pierrette, et al.. (1992). Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I. Journal of Medicinal Chemistry. 35(2). 346–350. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Safrun Mahmood Breakdown of academic impact, for papers by Lambro A. Johnson Breakdown of academic impact, for papers by J Collins Breakdown of academic impact, for papers by Shuang Shen Breakdown of academic impact, for papers by György Miklós Buzás Breakdown of academic impact, for papers by David J. Honor Breakdown of academic impact, for papers by K Thamprasert Breakdown of academic impact, for papers by Yurong Lu Breakdown of academic impact, for papers by James Owens Breakdown of academic impact, for papers by Takuji Fujisawa
Rankless by CCL
2026